Libertus Capital
VC Fund
London, United Kingdom
Libertus Capital is a VC fund in London focused on Blockchain and Software. Libertus Capital invests in companies that enhance and protect individual freedom and privacy.
- Total investments:
- 35
- Last investment:
- Lead investor:
- 34%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Libertus Capital invests in
Stages Libertus Capital invests in
Countries Libertus Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $2M–$10M
- Series A
- $6M–$19M
Investment Focus
Industry
- Blockchain 18 (51%)
- Software 8 (23%)
- Cryptocurrency 8 (23%)
- Financial Services 5 (14%)
- Information Technology 5 (14%)
Stage
- Series A 12 (34%)
- Seed 8 (23%)
- Funding Round 3 (9%)
- Series B 2 (6%)
- Series C 2 (6%)
Country
- United States 8 (23%)
- United Kingdom 3 (9%)
- Vietnam 2 (6%)
- Singapore 2 (6%)
- Canada 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Pamir Gelenbe
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 11 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
The Open Network Foundation
|
The Open Network (TON) is a layer-1 blockchain that facilitate faster transactions and build dApps. | $400M / Initial Coin Offering / Mar 20, 2025 | |
BillionToOne
|
BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to makepre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries.BillionToOne was founded in 2016 and is headquartered in Menlo Park, California. | $130M / Series D / Jun 21, 2024 | |
Summer.fi
|
Summer.fi is a decentralized finance (DeFi) platform that enables users to lend, borrow, and optimize crypto yields across protocols like Aave, Maker (Sky), and Morpho. It offers automated strategies through Lazy Summer vaults for passive yield and Summer.fi Pro for advanced leverage and position management. Originally known as Oasis.app, it is anon-custodial DeFi interface built by Oazo Apps Limited that simplifies portfolio automation and yield optimization. | $6M / Series A / Aug 15, 2023 | |
|
BillionToOne
|
BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to makepre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries.BillionToOne was founded in 2016 and is headquartered in Menlo Park, California. | $48.5M / Series C / Dec 15, 2022 | |
GitPOAP
|
GitPOAP is a decentralized reputation platform that displays POAPs for contributions and achievements made off-chain. | $4.3M / Seed / Aug 18, 2022 | |
Merkle Science
|
Merkle Science is a software company that offers predictive crypto risk and intelligence platforms for businesses and government agencies. It helps crypto companies, financial institutions, and government entities detect, investigate, and prevent illegal activities involving cryptocurrencies. The company's proprietary Behavioral Rule Engineenables their tools to go beyond blacklists so that compliance teams may fulfill their local KYC/AML obligations and industry players may stay keep pace with the industry’s increasingly complex illicit activities. Merkle Science was founded in 2018 and is headquartered in Singapore. | $19M / Series A / Aug 09, 2022 | |
|
Merkle Science
|
Merkle Science is a software company that offers predictive crypto risk and intelligence platforms for businesses and government agencies. It helps crypto companies, financial institutions, and government entities detect, investigate, and prevent illegal activities involving cryptocurrencies. The company's proprietary Behavioral Rule Engineenables their tools to go beyond blacklists so that compliance teams may fulfill their local KYC/AML obligations and industry players may stay keep pace with the industry’s increasingly complex illicit activities. Merkle Science was founded in 2018 and is headquartered in Singapore. | $19M / Series A / Aug 05, 2022 | |
Mintbase, Inc.
|
Minting NFT assets for real worlds value | $7.5M / Series A / Apr 19, 2022 | |
Oasis.app
|
Oasis.app is the platform allowing decentralized finance (Defi) users to borrow, multiply their exposure to cryptocurrency, and earn on their assets. | $6M / Series A / Apr 14, 2022 | |
|
BillionToOne
|
BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to makepre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries.BillionToOne was founded in 2016 and is headquartered in Menlo Park, California. | $125M / Series C / Mar 30, 2022 | |
| See all 35 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Libertus Capital invest in?
Libertus Capital invests primarily in Blockchain, Software and Cryptocurrency startups, most often at Series A and Seed stage. Most of the 35 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Libertus Capital's check size?
Libertus Capital typically joins rounds of $2M–$10M at Seed and $6M–$19M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Libertus Capital participates in.
How do I contact Libertus Capital?
Public channels for Libertus Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Libertus Capital?
The team at Libertus Capital includes Pamir Gelenbe (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
